Cargando…
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic
Autores principales: | Khialani, Bharat, MacCarthy, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398459/ https://www.ncbi.nlm.nih.gov/pubmed/32522820 http://dx.doi.org/10.1136/heartjnl-2020-317221 |
Ejemplares similares
-
Timing of intervention in aortic stenosis: a review of current and future strategies
por: Everett, Russell James, et al.
Publicado: (2018) -
Calculated plasma volume status predicts outcomes after transcatheter aortic valve implantation
por: Maznyczka, Annette Marie, et al.
Publicado: (2020) -
Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis
por: Khawaja, M Z, et al.
Publicado: (2014) -
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
por: Lutz, Matthias, et al.
Publicado: (2017) -
Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
por: Lachmann, Mark, et al.
Publicado: (2022)